National Research Corporation (NASDAQ:NRC) to Issue Quarterly Dividend of $0.16

Key Points

• National Research declared a quarterly dividend of $0.16 per share, payable October 9 to shareholders of record on September 25; the dividend yield is approximately 2.9%.
• The company reported quarterly EPS of $0.31, exceeding the consensus estimate of a $0.15 loss, while revenue of $35.39 million also topped estimates.
• Analyst sentiment is mixed but generally positive: the consensus rating is “Moderate Buy” with a $26 price target, compared with shares trading at $21.86.

National Research Corporation (NASDAQ:NRC - Get Free Report) declared a quarterly dividend on Wednesday, July 15th. Stockholders of record on Friday, September 25th will be paid a dividend of 0.16 per share on Friday, October 9th. This represents a c) dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Friday, September 25th.

National Research has increased its dividend payment by an average of 0.2%per year over the last three years.

National Research Price Performance

Shares of NASDAQ NRC opened at $21.86 on Wednesday. The stock has a market cap of $497.31 million, a P/E ratio of 87.44 and a beta of 0.35. The firm's 50-day simple moving average is $21.13 and its 200 day simple moving average is $19.47. National Research has a fifty-two week low of $11.01 and a fifty-two week high of $23.68. The company has a quick ratio of 0.65, a current ratio of 0.65 and a debt-to-equity ratio of 13.13.

National Research (NASDAQ:NRC - Get Free Report) last announced its earnings results on Tuesday, July 28th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $0.46. National Research had a net margin of 4.18% and a return on equity of 164.26%. The firm had revenue of $35.39 million during the quarter, compared to analyst estimates of $34.90 million.

Analyst Ratings Changes

NRC has been the subject of a number of research reports. Citizens Jmp increased their price target on National Research from $23.00 to $26.00 and gave the company a "market outperform" rating in a research note on Wednesday, July 29th. Wall Street Zen cut National Research from a "buy" rating to a "hold" rating in a research note on Saturday, August 15th. Finally, Weiss Ratings upgraded shares of National Research from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Friday, August 21st. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, National Research has an average rating of "Moderate Buy" and a consensus price target of $26.00.

National Research Company Profile

National Research Corporation, doing business as NRC Health, provides research, analytics and technology solutions to the health care industry. The company helps hospitals, health systems and other care organizations understand patient and consumer perceptions, improve the care experience and strengthen relationships with the communities they serve.

Its offerings include patient and employee experience measurement, market and consumer insights, reputation management, customer relationship tools and analytics designed to support service improvement and strategic decision-making.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.